FDA NDC Directory · JSON-LD · Markdown

TEZSPIRE

NDC 55513-112 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametezepelumab-ekko
Labeler / ManufacturerAmgen Inc
Marketing categoryBiologic License Application · App BLA761224
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTEZEPELUMAB (210 mg/1.9mL)
Marketing started20211217
Package count3

External sources

Source: openFDA. Public-domain (CC0).